New

Middle East and Africa Leukapheresis Market

2021

Middle East and Africa Leukapheresis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)

Publication Month: Nov 2021 | Report Code: TIPRE00025792 | No. of Pages: 121 | Category: Pharmaceuticals | Status: Published

Market Insights

Middle East and Africa Leukapheresis Market to Grow at a CAGR of 7.4% to reach US$ 6.20 million Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The leukapheresis market in Middle East & Africa is expected to grow from US$ 3.77 million in 2021 to US$ 6.20 million by 2028; it is estimated to grow at a CAGR of 7.4% from 2021 to 2028.

Blood transfusion is an integral part of the national health infrastructure and policies of various countries. Advancements in the medical industry have led to improvements in the treatment procedures of serious illnesses and injuries, which eventually has propelled the need for blood transfusion for patients’ survival. Growing awareness regarding the importance of blood transfusion and blood availability in healthcare services has led to rise in the number of people willing to donate their blood for medical causes. As per the World Health Organization (WHO) data, ~117.4 million blood donations were reported worldwide in 2018. Blood donors are usually classified to be voluntary unpaid, paid, and family/replacement, and as per the WHO claims, voluntary/unpaid donors are the major source of a reliable and adequate supply of blood. According to WHO data in 2019, blood donations by voluntary unpaid donors increased by 11.6 million from 2008 to 2015 in 139 countries in the world. The trend of blood donation is also gaining significant prominence in low and middle-income countries. According to the data presented during the CAG annual meeting 2017, ~13,000 procedures were performed on 1,087 patients in 2016. National programs developed and rolled out in many countries are further attracting a large number of platelet and blood donors. Thus, the rising number of eligible donors in different countries across the world is fostering the need for leukapheresis equipment that is used to separate the required blood components.

Middle East & Africa have been witnessing a growing number of COVID-19 cases since its outbreak. Economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and cannot implement any public health measures. Iran was in deep economic recession due to the US sanctions. Also, the major source of economic stabilization in Middle East countries is oil production and export. However, the recent pandemic is causing turbulence to the economies of the Middle East region. Further, the adoption of plasma therapy for covid patients is impacting the market in the positive way. UAE is turning to a century-old treatment for viral disease that is showing promise with patients. Known as Convalescent Plasma therapy, it involves taking virus-killing antibodies from the blood of people who have recovered from the disease and donating them to the critically ill. With anti-virals still undergoing human trials and a vaccine at least a year away, CP therapy is being seen as a vital stopgap measure against the pandemic in the region. On April 12, 2020, medics at Sheikh Khalifa Medical City in Abu Dhabi announced that they were treating a patient with the plasma of an Emirati who had recovered from the virus.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa leukapheresis market. The Middle East & Africa leukapheresis market is expected to grow at a good CAGR during the forecast period.
Middle East & Africa leukapheresis market

Get more information on this report :


Middle East & Africa Leukapheresis Market Segmentation

Middle East & Africa Leukapheresis Market – By Product Type

  • Leukapheresis Disposables
  • Leukapheresis Devices

Middle East & Africa Leukapheresis Market – By Application

  • Research Applications
  • Therapeutic Applications

Middle East & Africa Leukapheresis Market – By Product Type

  • Blood Component Providers and Blood Centers
  • Hospitals and Transfusion Centers
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes

Middle East & Africa Leukapheresis Market – By Country

  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

Middle East & Africa Leukapheresis Market – Companies Mentioned

  • Asahi Kasei Corporation
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • Terumo Corporation
  • STEMCELL Technologies Inc.
  • HemaCare
  • Macopharma
  • AllCells
  • BioIVT

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East & Africa Leukapheresis Market – By Product Type

1.3.2 Middle East & Africa Leukapheresis Market – By Application

1.3.3 Middle East & Africa Leukapheresis Market – By End User

1.3.4 Middle East & Africa Leukapheresis Market – By Country

2. Middle East & Africa Leukapheresis Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Leukapheresis – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinions

5. Middle East & Africa Leukapheresis Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Scaling Number of Voluntary Blood Donors

5.1.2 Surging Incidence of Hematologic Diseases

5.1.3 Increasing Elderly Population

5.2 Key Market Restraints

5.2.1 High Cost of Leukapheresis

5.3 Key Market Opportunities

5.3.1 Elevating Opportunities in Emerging Economies

5.4 Future Trends

5.4.1 Evolution in Therapeutic Apheresis

5.5 Impact Analysis

6. Middle East & Africa Leukapheresis – Market Analysis

6.1 Middle East & Africa Leukapheresis Market Revenue Forecast and Analysis

7. Middle East & Africa Leukapheresis Market Analysis – by Product Type

7.1 Overview

7.2 Middle East & Africa Leukapheresis Market Share by Product Type 2021 & 2028 (%)

7.3 Leukapheresis Devices

7.3.1 Overview

7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Apheresis Devices

7.3.2.1.1 Overview

7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Leukapheresis ColuMillions and Cell Separators

7.3.2.2.1 Overview

7.3.2.2.2 Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Leukoreduction Filters

7.3.2.3.1 Overview

7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)

7.4 Leukapheresis Disposables

7.4.1 Overview

7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)

8. Middle East & Africa Leukapheresis Market Analysis – by Application

8.1 Overview

8.2 Middle East & Africa Leukapheresis Market Share by Application 2021 & 2028 (%)

8.3 Research Applications

8.3.1 Overview

8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Million)

8.4 Therapeutic Applications

8.4.1 Overview

8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Leukapheresis Market Analysis – by End User

9.1 Overview

9.2 Middle East & Africa Leukapheresis Market Share by End-User 2021 & 2028 (%)

9.3 Pharmaceutical and Biotechnology Companies

9.3.1 Overview

9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)

9.4 Blood Component Providers and Blood Centers

9.4.1 Overview

9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)

9.6 Hospitals and Transfusion Centers

9.6.1 Overview

9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Leukapheresis Market – Country Analysis

10.1 Overview

10.1.1 Middle East & Africa: Leukapheresis Market, by Country, 2021 & 2028 (%)

10.1.1.1 Saudi Arabia: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1 Overview

10.1.1.1.2 Saudi Arabia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3 Saudi Arabia Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3.1 Saudi Arabia: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.1.4 Saudi Arabia: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.1.5 Saudi Arabia Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.2 UAE: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1 Overview

10.1.1.2.2 UAE: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3 UAE Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3.1 UAE: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.2.4 UAE: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.2.5 UAE Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.3 South Africa: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1 Overview

10.1.1.3.2 South Africa: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3 South Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3.1 South Africa: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.3.4 South Africa: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.3.5 South Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.4 Rest of Middle East & Africa: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)

10.1.1.4.1 Overview

10.1.1.4.2 Rest of Middle East & Africa: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3 Rest of Middle East & Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3.1 Rest of Middle East & Africa: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.4.4 Rest of Middle East & Africa: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.4.5 Rest of Middle East & Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

11. Middle East & Africa Leukapheresis Market – Impact of COVID-19 Pandemic

11.1 Impact Assessment of COVID-19 Pandemic

12. Middle East & Africa Leukapheresis Market – Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Asahi Kasei Corporation

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Fresenius SE & Co. KGaA

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Haemonetics Corporation

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Terumo Corporation

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 STEMCELL Technologies Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 HemaCare

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Macopharma

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 AllCells

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 BioIVT

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Saudi Arabia Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 2. Saudi Arabia Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 3. Saudi Arabia Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4. Saudi Arabia Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5. UAE Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 6. UAE Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 7. UAE Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8. UAE Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. South Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 10. South Africa Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 11. South Africa Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12. South Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Rest of Middle East & Africa Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 14. Rest of Middle East & Africa Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 15. Rest of Middle East & Africa Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. Rest of Middle East & Africa Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17. Organic Developments Done by Companies

Table 18. Inorganic Developments Done by Companies

Table 19. Glossary of Terms, Leukapheresis Market


LIST OF FIGURES

Figure 1. Middle East & Africa Leukapheresis Market Segmentation

Figure 2. Middle East & Africa Leukapheresis Market Segmentation, By country

Figure 3. Middle East & Africa Leukapheresis Market Overview

Figure 4. Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market

Figure 5. Saudi Arabia to Show Significant Growth During Forecast Period

Figure 6. Middle East & Africa Leukapheresis Market, Industry Landscape

Figure 7. Middle East & Africa PEST Analysis

Figure 8. Middle East & Africa Leukapheresis market impact analysis of driver and restraints

Figure 9. Middle East & Africa Leukapheresis Market – Revenue Forecast and Analysis to 2020-2028

Figure 10. Middle East & Africa Leukapheresis Market Share by Product Type 2021 & 2028 (%)

Figure 11. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. Middle East & Africa Leukapheresis Market Share by Application 2021 & 2028 (%)

Figure 17. Research Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Middle East & Africa Leukapheresis Market Share by End-User 2021 & 2028 (%)

Figure 20. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Middle East & Africa: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)

Figure 25. Middle East & Africa: Leukapheresis Market, by Country, 2021 & 2028 (%)

Figure 26. Saudi Arabia: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 27. UAE: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 28. South Africa: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 29. Rest of Middle East & Africa: Leukapheresis Market - Revenue and Forecast to 2028 (USD Million)

Figure 30. Impact Of COVID-19 Pandemic In Middle East & Africa Market



  1. Asahi Kasei Corporation                                 
  2. Fresenius SE & Co. KGaA                                
  3. Haemonetics Corporation                              
  4. Terumo Corporation                                        
  5. STEMCELL Technologies Inc.                          
  6. HemaCare  
  7. Macopharma
  8. AllCells
  9. BioIVT
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa leukapheresis market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the leukapheresis market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
TIPRE00025792
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.